过度的红细胞瘤的安第斯高地动物的凝血概况是否有利于高凝血?
Benoit Champigneulle1,2, François Caton3, Landry Seyve4
1Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.
Experimental physiology
|March 30, 2024
概括
生活在高海拔地区的过度红细胞瘤 (EE) 患者不会表现出高凝血状态. 这项研究没有发现EE高地动物血栓形成的风险增加,这挑战了以前的假设.
科学领域:
- 身体生理学 身体生理学
- 高度医学 高度医学
- 血液学 血液学 血液学
背景情况:
- 慢性山病 (CMS) 与高海拔人口的过度红细胞瘤 (EE) 有关.
- 此前对安第斯高地动物的EE,高凝血和血栓形成风险的研究产生了相互矛盾的结果.
- 了解EE中的凝血概况对于评估血栓形成风险至关重要.
研究的目的:
- 评估和比较安第斯山脉高地动物的凝血概况,有和没有过度红细胞瘤 (EE).
- 调查EE与高凝血能力之间的潜在联系,以及其对血栓形成风险的影响.
主要方法:
- 分析了30只EE+和15只EE-安第斯高地动物的凝血概况,高度为5100-5300米.
- 在本地和正常化 (40%) 血液中进行了旋转性血栓形成仪 (ROTEM).
- 测量了血栓生成,凝血因子水平和抑制剂水平.
主要成果:
- 在本地血红素时,EE+个体与EE-和低地人相比,表现出低凝度的特征.
- 正常化血红素改善了凝血时间,但在特定的ROTEM试验中,最大的凝血度仍然异常,表明血小板功能发生了变化.
- 血栓生成,凝血因子水平和标准凝血试验在所有组中基本正常.
结论:
- 在安第斯山脉高地动物中,过度的红细胞形成似乎不会促进高凝血状态.
- 这些发现表明,EE+个体没有增加血栓形成的内在风险.
- 改变了血小板活动,而不是前血栓状况,可能解释了观察到的一些凝血差异.
更多相关视频
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
356
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
8.3K
相关概念视频
01:24Disorders of Hemostasis
885
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
01:27Disorders of Erythrocytes
933
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
933
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K
01:09Coagulation
6.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.5K
01:24Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K